Prognosis of unrecognized coeliac disease as regards mortality: A population-based cohort study

Annals of Medicine

Volumn 41, Issue 7, 2009, Pages 508-515

  Lohi, Sini ^a   Mäki, Markku ^a,b   Rissanen, Harri ^c   Knekt, Paul ^c   Reunanen, Antti ^c   Kaukinen, Katri ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Antibody; Coeliac disease; Epidemiology; Mortality

Indexed keywords

ENDOMYSIUM ANTIBODY; IMMUNOGLOBULIN A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADULT; ARTICLE; BLOOD SAMPLING; CAUSE OF DEATH; CELIAC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FINLAND; FOLLOW UP; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; RESPIRATORY SYSTEM; RISK FACTOR; STROKE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; CELIAC DISEASE; COHORT STUDIES; FEMALE; FINLAND; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REGRESSION ANALYSIS; RISK; TRANSGLUTAMINASES;

EID: 70349969490     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.1080/07853890903036199     Document Type: Article

References (47)

1. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163:286-292
2. Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, et al. Prevalence of celiac disease among children in Finland. N Engl J Med. 2003;348:2517-2524
3. West J, Logan RF, Hill PG, Lloyd A, Lewis S Hubbard R. et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut. 2003;52:960-965
4. Bingley PJ, Williams AJ, Norcross AJ, Unsworth DJ, Lock RJ, Ness AR, et al. Undiagnosed coeliac disease at age seven: population based prospective birth cohort study. BMJ. 2004;328:322-323
5. Lohi S, Mustalahti K, Kaukinen K, Laurila K, Collin P, Rissanen H, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007;26:1217-1225
6. Logan RF. Screening for coeliac disease-has the time come for mass screening? Acta Paediatr Suppl. 1996;412:15-19
7. Kumar PJ. European and North American populations should be screened for coeliac disease. Gut. 2003;52:170-171
8. Fasano A. European and North American populations should be screened for coeliac disease. Gut. 2003;52:168-169
9. Young EH, Wareham NJ. Screening for coeliac disease: what evidence is required before population programmes could be considered? Arch Dis Child. 2004;89:499-500.
10. Hoffenberg EJ. Should all children be screened for celiac disease? Gastroenterology. 2005;128:S98-103.
11. Collin P. Should adults be screened for celiac disease? What are the benefits and harms of screening? Gastroenterology. 2005;128:S104-8.
12. Nielsen OH, Jacobsen O, Pedersen ER, Rasmussen SN, Petri M, Laulund S, et al. Non-tropical sprue. Malignant diseases and mortality rate. Scand J Gastroenterol. 1985;20:13-18
13. Logan RF, Rifkind EA, Turner ID, Ferguson A. Mortality in celiac disease. Gastroenterology. 1989;97:265-271
14. Cottone M, Termini A, Oliva L, Magliocco A, Marrone C, Orlando A, et al. Mortality and causes of death in celiac disease in a Mediterranean area. Dig Dis Sci. 1999;44: 2538-1.
15. Corrao G, Corazza GR, Bagnardi V, Brusco G, Ciacci C, Cottone M, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet. 2001;358:356-361
16. Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med. 2003;163:1566-1572
17. West J, Logan RF, Smith CJ, Hubbard RB, Card TR. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ. 2004;329:716-719
18. Viljamaa M, Kaukinen K, Pukkala E, Hervonen K, Reunala T, Collin P. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis. 2006;38:374-380
19. Anderson LA, McMillan SA, Watson RG, Monaghan P, Gavin AT, Fox C, et al. Malignancy and mortality in a population-based cohort of patients with coeliac disease or 'gluten sensitivity'. World J Gastroenterol. 2007;13:146-151
20. Solaymani-Dodaran M, West J, Logan RF. Long-term mortality in people with celiac disease diagnosed in childhood compared with adulthood: a population-based cohort study. Am J Gastroenterol. 2007;102:864-870
21. Johnston SD, Watson RG, McMillan SA, Sloan J, Love AH. Coeliac disease detected by screening is not silent*simply unrecognized. QJM. 1998;91:853-860
22. Metzger MH, Heier M, Maki M, Bravi E, Schneider A, Lowel H, et al. Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989-1998. Eur J Epidemiol. 2006;21:359-365
23. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Carlsson R, Johansson SE, et al. Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol. 2004;39:1280-1288
24. Rostom A, Dube C, Cranney A, Saloojee N, Sy R, Garritty C, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology. 2005; 128:S38-6.
25. Aromaa A, Heliovaara M, Impivaara O, Knekt P, Maatela J. The execution of the Mini-Finland Health Survey. Part 1: Aims, methods and study population. Helsinki and Turku: the Social Insurance Institution; 1989 (in Finnish with English summary).
26. Lehtonen R, Kuusela V. The execution of the Mini-Finland Health Survey. Part 5: Statistical efficiency of the Mini-Finland Health Survey's sampling design. Helsinki and Turku: the Social Insurance Institution; 1986 (in Finnish with English summary).
27. Sulkanen S, Halttunen T, Laurila K, Kolho KL, Korponay-Szabo IR, Sarnesto A, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology. 1998;115:1322-1328
28. Stern M. Working Group on Serologic Screening for Celiac Disease. Comparative evaluation of serologic tests for celiac disease: a European initiative toward standardization. J Pediatr Gastroenterol Nutr. 2000;31:513-519
29. Hill ID. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations? Gastroenterology. 2005;128:S25-32.
30. Lohi S, Maki M, Montonen J, Knekt P, Pukkala E, Reunanen A, et al. Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study. Gut. 2009;58:643-647
31. Causes of death, description of statistics. Available at: http://www.tilastokeskus.fi/meta/til/ksyyt-en.html (accessed 20 January 2008).
32. Green PH, Jabri B. Coeliac disease. Lancet. 2003;362: 383-391
33. Gao Y, Kristinsson SY, Goldin LR, Bjorkholm M, Caporaso NE, Landgren O. Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association. Gastroenterology. 2009;136:91-98
34. West J, Logan RF, Card TR, Smith C, Hubbard R. Risk of vascular disease in adults with diagnosed coeliac disease:-a population-based study. Aliment Pharmacol Ther. 2004;20:73-79 (Pubitemid 38938721)
35. Wei L, Spiers E, Reynolds N, Walsh S, Fahey T, MacDonald TM. The association between coeliac disease and cardiovascular disease. Aliment Pharmacol Ther. 2008;27:514-519
36. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288:2015-2022
37. Dickey W, Ward M, Whittle CR, Kelly MT, Pentieva K, Horigan G, et al. Homocysteine and related B-vitamin status in coeliac disease: Effects of gluten exclusion and histological recovery. Scand J Gastroenterol. 2008;43:682-688
38. Milani RV, Lavie CJ. Homocysteine: the Rubik's cube of cardiovascular risk factors. Mayo Clin Proc. 2008;83:1200-1202
39. Ludvigsson JF, Wahlstrom J, Grunewald J, Ekbom A, Montgomery SM. Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax. 2007;62:23-28 (Pubitemid 46101762)
40. Stevens FM, Connolly CE, Murray JP, McCarthy CF. Lung cavities in patients with coeliac disease. Digestion. 1990;46:72-80.
41. Douglas JG, Gillon J, Logan RF, Grant IW, Crompton GK. Sarcoidosis and coeliac disease: an association? Lancet. 1984;2:13-15
42. Card TR, Solaymani-Dodaran M, Hubbard R, Logan RF, West J. Is an internal comparison better than using national data when estimating mortality in longitudinal studies? J Epidemiol Community Health. 2006;60:819-821
43. Cataldo F, Marino V, Ventura A, Bottaro G, Corazza GR. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Italian Society of Paediatric Gastroenterology and Hepatol-ogy (SIGEP) and 'Club del Tenue' Working Groups on Coeliac Disease. Gut. 1998;42:362-365
44. Gissler M, Haukka J. Finnish health and social welfare registers in epidemiological research. Norsk Epidemiologi. 2004;14:113-120
45. Fabiani E, Catassi C. International Working Group. The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of coeliac disease. Results of an international multi-centre study. International Working Group on Eu-tTG. Eur J Gastroenterol Hepatol. 2001; 13:659-665 (Pubitemid 32547864)
46. Abrams JA, Diamond B, Rotterdam H, Green PH. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci. 2004;49:546-550
47. West J, Logan RF, Hill PG, Khaw KT The iceberg of celiac disease: what is below the waterline? Clin Gastroenterol Hepatol. 2007;5:59-62.